<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39532773</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-0973</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Nov</Month><Day>12</Day></PubDate></JournalIssue><Title>Infection</Title><ISOAbbreviation>Infection</ISOAbbreviation></Journal><ArticleTitle>Burden of post-acute COVID-19 sequelae in healthcare workers and its course over a 30-month period-results from a prospective multicentre cohort.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s15010-024-02418-3</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">As healthcare workers (HCW) have been disproportionally affected by COVID-19, its post-acute sequelae (PASC) in HCW can impact healthcare systems. We assessed the burden and course of PASC in HCW over a 30-month period.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a prospective multicentre HCW cohort in Switzerland, PASC surveys were conducted in 03/2021, 09/2021, 06/2022, 04/2023, and 10/2023. Stratified by viral variant at first infection, the prevalence of PASC symptoms, self-experienced PASC and the Post-COVID Functional Status (PCFS) were analysed cross-sectionally in 10/2023, self-perceived success of therapeutic measures used was assessed. The evolution of PASC symptoms and PCFS in Wild-type and non-Wild-type infected HCW compared to uninfected controls was analysed longitudinally across all surveys.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In cross-sectional analysis, 1704 HCW (median age 47&#xa0;years, 82.2% female) were included. Thereof, 30.7% reported&#x2009;&#x2265;&#x2009;1 PASC symptom in 10/2023, with 115 (6.7%) stating to have or have had PASC. Both were most common after Wild-type infection compared to other variants. Overall, 17/115 (15%) indicated relevant/severe restrictions in their daily activities and of 85 (74%) that tried&#x2009;&#x2265;&#x2009;1 measure against their symptoms, 69 (81%) reported having benefitted. Longitudinal analysis (n&#x2009;=&#x2009;653) showed a significantly higher proportion of Wild-type infected HCW to report PASC symptoms compared to controls in 03/2021 (+&#x2009;21%, 95% CI 4-39), with decreasing trend (+&#x2009;7%, 95%CI -10-25 in 10/2023). This effect was not evident for non-Wild-type infected HCW.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Over a 30&#xa0;month period, overall PASC burden in our HCW cohort decreased, although 1% still experience relevant restrictions in their daily life; Wild-type infected individuals show the highest disease burden.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>D&#xf6;rr</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-6033-1037</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Infection Prevention and Travel Medicine, Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, Rorschacherstrasse 95, 9007, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strahm</LastName><ForeName>Carol</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-1713-262X</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Infection Prevention and Travel Medicine, Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, Rorschacherstrasse 95, 9007, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;sewell</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Infection Prevention and Travel Medicine, Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, Rorschacherstrasse 95, 9007, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ballouz</LastName><ForeName>Tala</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-2334-8600</Identifier><AffiliationInfo><Affiliation>Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kocan</LastName><ForeName>Emina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Geriatric Clinic St, Gallen, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cusini</LastName><ForeName>Alexia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Cantonal Hospital Graub&#xfc;nden, Chur, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goppel</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Clienia Littenheid, Littenheid, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gr&#xe4;ssli</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><Identifier Source="ORCID">0009-0009-3925-8811</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Infection Prevention and Travel Medicine, Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, Rorschacherstrasse 95, 9007, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf6;ller</LastName><ForeName>J Carsten</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0003-1718-4486</Identifier><AffiliationInfo><Affiliation>Center for Neurological Rehabilitation, Zihlschlacht, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puhan</LastName><ForeName>Milo A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-4721-1879</Identifier><AffiliationInfo><Affiliation>Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Risch</LastName><ForeName>Lorenz</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2692-6699</Identifier><AffiliationInfo><Affiliation>Labormedizinisches Zentrum Dr Risch Ostschweiz AG, Buchs, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Private Universit&#xe4;t Im F&#xfc;rstentum Liechtenstein, Triesen, Liechtenstein.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre of Laboratory Medicine, University Institute of Clinical Chemistry, University of Bern, Inselspital, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruetti</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fuerstenland Toggenburg Hospital Group, Wil, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlegel</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2847-4956</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Infection Prevention and Travel Medicine, Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, Rorschacherstrasse 95, 9007, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stocker</LastName><ForeName>Reto</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9869-7894</Identifier><AffiliationInfo><Affiliation>Hirslanden Clinic, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Kietzell</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hirslanden Clinic Stephanshorn, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vuichard-Gysin</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-1115-4035</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, Thurgau Hospital Group, Muensterlingen, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Research and Development, Swiss National Centre for Infection Prevention (Swissnoso), Berne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuster</LastName><ForeName>Stefan P</ForeName><Initials>SP</Initials><Identifier Source="ORCID">0000-0002-0525-6529</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Infection Prevention and Travel Medicine, Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, Rorschacherstrasse 95, 9007, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahlert</LastName><ForeName>Christian R</ForeName><Initials>CR</Initials><Identifier Source="ORCID">0000-0002-0784-3276</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Infection Prevention and Travel Medicine, Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, Rorschacherstrasse 95, 9007, St. Gallen, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases and Hospital Epidemiology, Children's Hospital of Eastern Switzerland, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kohler</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0427-8934</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Infection Prevention and Travel Medicine, Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, Rorschacherstrasse 95, 9007, St. Gallen, Switzerland. Philipp.kohler@kssg.ch.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland. Philipp.kohler@kssg.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>SURPRISE (SURveillance of infectious diseases among health Professionals In SwitzErland) Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>YTCR 12/22</GrantID><Agency>Schweizerische Akademie der Medizinischen Wissenschaften</Agency><Country/></Grant><Grant><GrantID>31CA30_196544</GrantID><Agency>Schweizerischer Nationalfonds zur F&#xf6;rderung der Wissenschaftlichen Forschung</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Infection</MedlineTA><NlmUniqueID>0365307</NlmUniqueID><ISSNLinking>0300-8126</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Disease burden</Keyword><Keyword MajorTopicYN="N">Healthcare workers</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement><b>Declarations</b> <b>Conflict of interest</b> All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. <b>Ethical approval</b> Written consent was obtained by all participants at study inclusion. The study was approved by the Ethics Committee of Eastern Switzerland (#2020&#x2013;00502).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>13</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>13</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>12</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39532773</ArticleId><ArticleId IdType="doi">10.1007/s15010-024-02418-3</ArticleId><ArticleId IdType="pii">10.1007/s15010-024-02418-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ford ND, et al. Long COVID and significant activity limitation among adults, by age&#x2013;United States, June 1&#x2013;13, 2022, to June 7&#x2013;19, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(32):866&#x2013;70. https://doi.org/10.15585/mmwr.mm7232a3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7232a3</ArticleId><ArticleId IdType="pubmed">37561665</ArticleId><ArticleId IdType="pmc">10415000</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, et al. The pandemic toll and post-acute sequelae of SARS-CoV-2 in healthcare workers at a Swiss University Hospital. Prev Med Rep. 2022;29:101899. https://doi.org/10.1016/j.pmedr.2022.101899 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmedr.2022.101899</ArticleId><ArticleId IdType="pubmed">35822203</ArticleId><ArticleId IdType="pmc">9263685</ArticleId></ArticleIdList></Reference><Reference><Citation>Praschan N, et al. Implications of COVID-19 sequelae for health-care personnel. Lancet Respir Med. 2021;9(3):230&#x2013;1. https://doi.org/10.1016/S2213-2600(20)30575-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30575-0</ArticleId><ArticleId IdType="pubmed">33444540</ArticleId><ArticleId IdType="pmc">7834418</ArticleId></ArticleIdList></Reference><Reference><Citation>W. H. Organization. Post COVID-19 condition. https://www.who.int/teams/health-care-readiness/post-covid-19-condition . Accessed 20 Feb 2024</Citation></Reference><Reference><Citation>O&#x2019;Mahoney LL, et al. The prevalence and long-term health effects of long covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. 2023;55:101762. https://doi.org/10.1016/j.eclinm.2022.101762 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Kisiel MA, et al. Predictors of post-COVID-19 and the impact of persistent symptoms in non-hospitalized patients 12 months after COVID-19 with a focus on work ability. Ups J Med Sci. 2022. https://doi.org/10.48101/ujms.v127.8794 .</Citation><ArticleIdList><ArticleId IdType="doi">10.48101/ujms.v127.8794</ArticleId><ArticleId IdType="pubmed">35991464</ArticleId><ArticleId IdType="pmc">9383047</ArticleId></ArticleIdList></Reference><Reference><Citation>Braig S, et al. Post-COVID syndrome and work ability 9&#x2013;12 months after a SARS-CoV-2 infection among over 9000 employees from the general population. IJID Reg. 2024;10:67&#x2013;74. https://doi.org/10.1016/j.ijregi.2023.11.015 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijregi.2023.11.015</ArticleId><ArticleId IdType="pubmed">38532741</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerksieck P, et al. Post COVID-19 condition, work ability and occupational changes in a population-based cohort. Lancet Reg Health Eur. 2023. https://doi.org/10.1016/j.lanepe.2023.100671 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100671</ArticleId><ArticleId IdType="pubmed">37366496</ArticleId><ArticleId IdType="pmc">10287546</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballouz T, et al. Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study. BMJ. 2023. https://doi.org/10.1136/bmj-2022-074425 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-074425</ArticleId><ArticleId IdType="pubmed">37257891</ArticleId><ArticleId IdType="pmc">10230608</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Q, et al. COVID-19 illness severity and 2-year prevalence of physical symptoms: an observational study in Iceland, Sweden, Norway and Denmark. Lancet Reg Health Eur. 2023;35:100756. https://doi.org/10.1016/j.lanepe.2023.100756 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100756</ArticleId><ArticleId IdType="pubmed">38115966</ArticleId><ArticleId IdType="pmc">10730314</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, et al. True prevalence of long-COVID in a nationwide, population cohort study. Nat Commun. 2023. https://doi.org/10.1038/s41467-023-43661-w .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-43661-w</ArticleId><ArticleId IdType="pubmed">38036541</ArticleId><ArticleId IdType="pmc">10689486</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahlert CR, et al. Post-acute sequelae after severe acute respiratory syndrome coronavirus 2 infection by viral variant and vaccination status: a multicenter cross-sectional study. Clin Infect Dis. 2023;77(2):194&#x2013;202. https://doi.org/10.1093/cid/ciad143 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciad143</ArticleId><ArticleId IdType="pubmed">36905145</ArticleId><ArticleId IdType="pmc">10371307</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerdal A. Fatigue severity scale. In: Maggino F, editor. Encyclopedia of quality of life and well-being research. Cham: Springer International Publishing; 2020. p. 1&#x2013;5.</Citation></Reference><Reference><Citation>Klok FA, et al. The post-COVID-19 functional status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020. https://doi.org/10.1183/13993003.01494-2020 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId><ArticleId IdType="pmc">7236834</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;46. https://doi.org/10.1038/s41579-022-00846-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId><ArticleId IdType="pmc">9839201</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahlert CR, et al. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers&#x2013;a multicentre cross-sectional study. Clin Microbiol Infect. 2021;27(9):1336&#x2013;44. https://doi.org/10.1016/j.cmi.2021.05.014 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.014</ArticleId><ArticleId IdType="pubmed">34020033</ArticleId><ArticleId IdType="pmc">8131187</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Choi T, Al-Aly Z. Postacute sequelae of SARS-CoV-2 infection in the pre-delta, delta, and omicron eras. N Engl J Med. 2024. https://doi.org/10.1056/NEJMoa2403211 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2403211</ArticleId><ArticleId IdType="pubmed">39476351</ArticleId></ArticleIdList></Reference><Reference><Citation>Strahm C, et al. Evolution of symptoms compatible with post-acute sequelae of SARS-CoV-2 (PASC) after Wild-type and/or omicron BA.1 infection: a prospective healthcare worker cohort. J Infect. 2024;88(2):200&#x2013;2. https://doi.org/10.1016/j.jinf.2023.12.002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2023.12.002</ArticleId><ArticleId IdType="pubmed">38070691</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344&#x2013;9. https://doi.org/10.1016/j.jclinepi.2007.11.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.11.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla AK, et al. An observational multi-centric COVID-19 sequelae study among health care workers. Lancet Reg Health Southeast Asia. 2023;10:100129. https://doi.org/10.1016/j.lansea.2022.100129 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lansea.2022.100129</ArticleId><ArticleId IdType="pubmed">36531928</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA. 2021;325(19):2015&#x2013;6. https://doi.org/10.1001/jama.2021.5612 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5612</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId><ArticleId IdType="pmc">8027932</ArticleId></ArticleIdList></Reference><Reference><Citation>Fouad MM, Zawilla NH, Maged LA. Work performance among healthcare workers with post COVID-19 syndrome and its relation to antibody response. Infection. 2023;51(4):839&#x2013;49. https://doi.org/10.1007/s15010-022-01942-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01942-4</ArticleId><ArticleId IdType="pubmed">36308638</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, et al. Natural history of long-COVID in a nationwide, population cohort study. Nat Commun. 2023;14(1):3504. https://doi.org/10.1038/s41467-023-39193-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-39193-y</ArticleId><ArticleId IdType="pubmed">37311808</ArticleId><ArticleId IdType="pmc">10263377</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021;4(2):e210830. https://doi.org/10.1001/jamanetworkopen.2021.0830 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId><ArticleId IdType="pmc">7896197</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nat Med. 2023;29(9):2347&#x2013;57. https://doi.org/10.1038/s41591-023-02521-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId><ArticleId IdType="pmc">10504070</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikkelsen ME, Abramoff B, COVID-19: management of adults with persistent symptoms following acute illness (&#x201c;long COVID&#x201d;). In: Finlay G (eds) Wolters Kluwer, 2024. Accessed on 16 Jul 2024</Citation></Reference><Reference><Citation>Herrera JE, et al. Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV-2 infection (PASC) patients. PM R. 2021;13(9):1027&#x2013;43. https://doi.org/10.1002/pmrj.12684 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12684</ArticleId><ArticleId IdType="pubmed">34346558</ArticleId><ArticleId IdType="pmc">8441628</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayyerabadi M, et al. Vaccination after developing long COVID: impact on clinical presentation, viral persistence, and immune responses. Int J Infect Dis. 2023;136:136&#x2013;45. https://doi.org/10.1016/j.ijid.2023.09.006 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.09.006</ArticleId><ArticleId IdType="pubmed">37717649</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran VT, Perrodeau E, Saldanha J, Pane I, Ravaud P. Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of patients with long covid: target trial emulation based on ComPaRe e-cohort. BMJ Med. 2023;2(1):e000229. https://doi.org/10.1136/bmjmed-2022-000229 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000229</ArticleId><ArticleId IdType="pubmed">36910458</ArticleId><ArticleId IdType="pmc">9978748</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E, et al. The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): a prospective cohort study. Vaccine. 2022;40(32):4424&#x2013;31. https://doi.org/10.1016/j.vaccine.2022.05.090 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.05.090</ArticleId><ArticleId IdType="pubmed">35725782</ArticleId><ArticleId IdType="pmc">9170535</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>